VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib
Clinical trial NCT03400176 · TERMINATED
Trial details
- NCT number
- NCT03400176
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2023-09-29
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.